IMDX · NASDAQ · Medical - Diagnostics & Research

Insight Molecular Diagnostics (IMDX)

Develops molecular diagnostic tests for transplant rejection and oncology therapy programs.

$4.08
After hours−0.03 (−0.73%)
At close$4.11(+2.49%)